4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-014006
Chief Operating Officer sold 10,365 shares at an average $50.74 ($525,939)
- Chief Operating Officer acquired 10,365 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Goldshleger Ilya Chief Operating Officer | 2024-02-09 | Option exercise 10b5-1 | +5,365 | $18.90 | $101,399 | 31,840 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-09 | Option exercise 10b5-1 | +5,000 | $23.04 | $115,200 | 36,840 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-09 | Sale 10b5-1 | −5,365 | $50.50 | $270,939 | 31,475 | D |
| Goldshleger Ilya Chief Operating Officer | 2024-02-09 | Sale 10b5-1 | −5,000 | $51.00 | $255,000 | 26,475 | D |
| Derivatives | |||||||
| Goldshleger Ilya Chief Operating Officer | 2024-02-09 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,365 | 3,995 | D | ||
| Goldshleger Ilya Chief Operating Officer | 2024-02-09 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 25,000 | D | ||
| Open-market sales · 10,365 sh · avg $50.74 · $525,939 | |||||||
Loading xslF345X05/ownership.xml…